363 related articles for article (PubMed ID: 31120606)
1. Fluconazole plus flucytosine is a good alternative therapy for non-HIV and non-transplant-associated cryptococcal meningitis: A retrospective cohort study.
Li Z; Liu Y; Chong Y; Li X; Jie Y; Zheng X; Yan Y
Mycoses; 2019 Aug; 62(8):686-691. PubMed ID: 31120606
[TBL] [Abstract][Full Text] [Related]
2. Treatment of acute cryptococcal meningitis in HIV infected adults, with an emphasis on resource-limited settings.
Sloan D; Dlamini S; Paul N; Dedicoat M
Cochrane Database Syst Rev; 2008 Oct; (4):CD005647. PubMed ID: 18843697
[TBL] [Abstract][Full Text] [Related]
3. AMBIsome Therapy Induction OptimisatioN (AMBITION): High Dose AmBisome for Cryptococcal Meningitis Induction Therapy in sub-Saharan Africa: Study Protocol for a Phase 3 Randomised Controlled Non-Inferiority Trial.
Lawrence DS; Youssouf N; Molloy SF; Alanio A; Alufandika M; Boulware DR; Boyer-Chammard T; Chen T; Dromer F; Hlupeni A; Hope W; Hosseinipour MC; Kanyama C; Lortholary O; Loyse A; Meya DB; Mosepele M; Muzoora C; Mwandumba HC; Ndhlovu CE; Niessen L; Schutz C; Stott KE; Wang D; Lalloo DG; Meintjes G; Jaffar S; Harrison TS; Jarvis JN
Trials; 2018 Nov; 19(1):649. PubMed ID: 30470259
[TBL] [Abstract][Full Text] [Related]
4. HIV-Associated Cryptococcal Meningitis Patients Treated with Amphotericin B Deoxycholate Plus Flucytosine under Routine Care Conditions in a Referral Center in São Paulo, Brazil.
Vidal JE; de Albuquerque Moraes C; de Siqueira REB; Miranda NFB; Marcusso R; Boulware DR; de Oliveira ACP
Mycopathologia; 2021 Mar; 186(1):93-102. PubMed ID: 33258083
[TBL] [Abstract][Full Text] [Related]
5. Triple therapy versus amphotericin B plus flucytosine for the treatment of non-HIV- and non-transplant-associated cryptococcal meningitis: retrospective cohort study.
Xu L; Liu J; Zhang Q; Li M; Liao J; Kuang W; Zhu C; Yi H; Peng F
Neurol Res; 2018 May; 40(5):398-404. PubMed ID: 29560802
[TBL] [Abstract][Full Text] [Related]
6. Factors associated with early mycological clearance in HIV-associated cryptococcal meningitis.
Concha-Velasco F; González-Lagos E; Seas C; Bustamante B
PLoS One; 2017; 12(3):e0174459. PubMed ID: 28355252
[TBL] [Abstract][Full Text] [Related]
7. Comparison of amphotericin B deoxycholate in combination with either flucytosine or fluconazole, and voriconazole plus flucytosine for the treatment of HIV-associated cryptococcal meningitis: a prospective multicenter study in China.
Zhao T; Xu X; Wu Y; Zhang W; Zeng Q; Lu Y; Yang T; Zhou G; Yu J; Lan K; Harypursat V; Chen Y
BMC Infect Dis; 2022 Aug; 22(1):677. PubMed ID: 35941618
[TBL] [Abstract][Full Text] [Related]
8. Combination antifungal therapy for cryptococcal meningitis.
Day JN; Chau TTH; Wolbers M; Mai PP; Dung NT; Mai NH; Phu NH; Nghia HD; Phong ND; Thai CQ; Thai LH; Chuong LV; Sinh DX; Duong VA; Hoang TN; Diep PT; Campbell JI; Sieu TPM; Baker SG; Chau NVV; Hien TT; Lalloo DG; Farrar JJ
N Engl J Med; 2013 Apr; 368(14):1291-1302. PubMed ID: 23550668
[TBL] [Abstract][Full Text] [Related]
9. Comparison of flucytosine and fluconazole combined with amphotericin B for the treatment of HIV-associated cryptococcal meningitis: a systematic review and meta-analysis.
Yao ZW; Lu X; Shen C; Lin DF
Eur J Clin Microbiol Infect Dis; 2014 Aug; 33(8):1339-44. PubMed ID: 24550039
[TBL] [Abstract][Full Text] [Related]
10. Leave no one behind: response to new evidence and guidelines for the management of cryptococcal meningitis in low-income and middle-income countries.
Loyse A; Burry J; Cohn J; Ford N; Chiller T; Ribeiro I; Koulla-Shiro S; Mghamba J; Ramadhani A; Nyirenda R; Aliyu SH; Wilson D; Le T; Oladele R; Lesikari S; Muzoora C; Kalata N; Temfack E; Mapoure Y; Sini V; Chanda D; Shimwela M; Lakhi S; Ngoma J; Gondwe-Chunda L; Perfect C; Shroufi A; Andrieux-Meyer I; Chan A; Schutz C; Hosseinipour M; Van der Horst C; Klausner JD; Boulware DR; Heyderman R; Lalloo D; Day J; Jarvis JN; Rodrigues M; Jaffar S; Denning D; Migone C; Doherty M; Lortholary O; Dromer F; Stack M; Molloy SF; Bicanic T; van Oosterhout J; Mwaba P; Kanyama C; Kouanfack C; Mfinanga S; Govender N; Harrison TS
Lancet Infect Dis; 2019 Apr; 19(4):e143-e147. PubMed ID: 30344084
[TBL] [Abstract][Full Text] [Related]
11. Amphotericin B with or without flucytosine followed by fluconazole as primary therapy for cryptococcal meningitis in patients with AIDS.
Jaruratanasirikul S
Southeast Asian J Trop Med Public Health; 1996 Dec; 27(4):719-23. PubMed ID: 9253873
[TBL] [Abstract][Full Text] [Related]
12. Amphotericin B and fluconazole, a potent combination therapy for cryptococcal meningitis.
Larsen RA; Bauer M; Thomas AM; Graybill JR
Antimicrob Agents Chemother; 2004 Mar; 48(3):985-91. PubMed ID: 14982793
[TBL] [Abstract][Full Text] [Related]
13. Combination flucytosine and high-dose fluconazole compared with fluconazole monotherapy for the treatment of cryptococcal meningitis: a randomized trial in Malawi.
Nussbaum JC; Jackson A; Namarika D; Phulusa J; Kenala J; Kanyemba C; Jarvis JN; Jaffar S; Hosseinipour MC; Kamwendo D; van der Horst CM; Harrison TS
Clin Infect Dis; 2010 Feb; 50(3):338-44. PubMed ID: 20038244
[TBL] [Abstract][Full Text] [Related]
14. Cryptococcal Meningitis Treatment Strategies Affected by the Explosive Cost of Flucytosine in the United States: A Cost-effectiveness Analysis.
Merry M; Boulware DR
Clin Infect Dis; 2016 Jun; 62(12):1564-8. PubMed ID: 27009249
[TBL] [Abstract][Full Text] [Related]
15. Triple therapy combined with ventriculoperitoneal shunts can improve neurological function and shorten hospitalization time in non-HIV cryptococcal meningitis patients with increased intracranial pressure.
Li M; Liu J; Deng X; Gan Q; Wang Y; Xu X; Jiang Y; Peng F
BMC Infect Dis; 2020 Nov; 20(1):844. PubMed ID: 33198666
[TBL] [Abstract][Full Text] [Related]
16. Fluconazole and amphotericin B for cryptococcal meningitis.
Clark AB; Lobo BL; Gelfand MS
Ann Pharmacother; 1996 Dec; 30(12):1408-10. PubMed ID: 8968453
[TBL] [Abstract][Full Text] [Related]
17. Combination antifungal therapies for HIV-associated cryptococcal meningitis: a randomised trial.
Brouwer AE; Rajanuwong A; Chierakul W; Griffin GE; Larsen RA; White NJ; Harrison TS
Lancet; 2004 May; 363(9423):1764-7. PubMed ID: 15172774
[TBL] [Abstract][Full Text] [Related]
18. Treatment of cryptococcal meningitis associated with the acquired immunodeficiency syndrome. National Institute of Allergy and Infectious Diseases Mycoses Study Group and AIDS Clinical Trials Group.
van der Horst CM; Saag MS; Cloud GA; Hamill RJ; Graybill JR; Sobel JD; Johnson PC; Tuazon CU; Kerkering T; Moskovitz BL; Powderly WG; Dismukes WE
N Engl J Med; 1997 Jul; 337(1):15-21. PubMed ID: 9203426
[TBL] [Abstract][Full Text] [Related]
19. Relationship between intracranial pressure and antifungal agents levels in the CSF of patients with cryptococcal meningitis.
Wirth F; de Azevedo MI; Pilla C; Aquino VR; Neto GW; Goldani LZ
Med Mycol; 2018 Apr; 56(3):257-262. PubMed ID: 28992308
[TBL] [Abstract][Full Text] [Related]
20. Antifungal Combinations for Treatment of Cryptococcal Meningitis in Africa.
Molloy SF; Kanyama C; Heyderman RS; Loyse A; Kouanfack C; Chanda D; Mfinanga S; Temfack E; Lakhi S; Lesikari S; Chan AK; Stone N; Kalata N; Karunaharan N; Gaskell K; Peirse M; Ellis J; Chawinga C; Lontsi S; Ndong JG; Bright P; Lupiya D; Chen T; Bradley J; Adams J; van der Horst C; van Oosterhout JJ; Sini V; Mapoure YN; Mwaba P; Bicanic T; Lalloo DG; Wang D; Hosseinipour MC; Lortholary O; Jaffar S; Harrison TS;
N Engl J Med; 2018 Mar; 378(11):1004-1017. PubMed ID: 29539274
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
